Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vaccine ; 11(14): 1386-9, 1993 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8310758

RESUMO

Temperature-sensitive (ts) mutants of Salmonella typhi were isolated following treatment with nitrosoguanidine, and characterized with respect to cut-off temperature, ts phenotype and reversion frequency. Linkage of the ts mutations to selectable chromosomal markers was established by generalized transduction with bacteriophage phage Vi I, and the appropriate antibiotic resistances were transduced into the ts mutants. Multiple mutant S. typhi were then constructed by combining three independent ts mutations in one strain, utilizing linkage of three of the mutations to erythromycin-, streptomycin- and methylglyoxal-resistance. Several recombinants are genetically stable, with calculated reversion rates of less than 10(-22), and induce both protection from intraperitoneal challenge with the virulent parental wild-type S. typhi in mice and the formation of antibodies to the somatic O-9 and O-12, the flagellar H and the capsular Vi antigens.


Assuntos
Salmonella typhi/genética , Salmonella typhi/imunologia , Febre Tifoide/prevenção & controle , Vacinas Tíficas-Paratíficas/genética , Vacinas Tíficas-Paratíficas/uso terapêutico , Animais , Imunização , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Mutação/genética , Fenótipo , Sensibilidade e Especificidade , Temperatura , Febre Tifoide/imunologia , Vacinas Atenuadas/uso terapêutico
2.
Otolaryngol Head Neck Surg ; 95(3 Pt 1): 319-23, 1986 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-3108780

RESUMO

A wearable device for transcutaneous electrical tinnitus suppression (ETS) has recently been reported to be effective for relief of tinnitus. Twenty patients with sensorineural hearing loss and tinnitus participated in a double-blind crossover study. Both active devices and internally disconnected placebo devices, supplied by the manufacturer, were used. Reduction in severity of tinnitus was reported by 2 of 20 patients (10%) with the active device and by 4 of 20 (20%) with the placebo device. Fifteen of 20 (75%) had no relief with either device. Those who preferred the placebo device, however, reported only minimal relief, while one of the two who preferred the active device stated it had reduced tinnitus severity by 70% to 80%. This patient was recalled for a series of one-hour test sessions, during which either an active or placebo device was used, according to a random schedule. On each of four on trials, the score for severity of tinnitus for each ear decreased by at least 50% (median = 70%), while in three off trials, the severity of tinnitus was unchanged or decreased by up to 30% (median = 16%). We conclude that the Theraband headset is effective for a small proportion of patients with sensorineural hearing loss and tinnitus.


Assuntos
Terapia por Estimulação Elétrica , Zumbido/terapia , Adulto , Idoso , Audiometria de Tons Puros , Método Duplo-Cego , Feminino , Perda Auditiva Neurossensorial/complicações , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Distribuição Aleatória , Zumbido/complicações , Estimulação Elétrica Nervosa Transcutânea
3.
Infect Immun ; 51(1): 102-9, 1986 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3510162

RESUMO

Cerulenin, an inhibitor of fatty acid biosynthesis, has been used to study the role of the plasma membrane in germination of Candida albicans. To further elucidate this association, spontaneous, cerulenin-resistant mutants of C. albicans were isolated. Two of the mutants, 4918-2 and 4918-10, were compared biochemically with wild-type cells (4918). All strains grew equally well at 37 degrees C and synthesized fatty acids at comparable rates in the absence of the drug. In the presence of cerulenin, wild-type cells did not proceed through a logarithmic growth stage and exhibited a significantly impaired ability to incorporate [3H]acetate into newly synthesized lipid material. All strains were examined ultrastructurally. Alterations were observed in the membranous structures of cerulenin-treated wild-type cells. Such changes were not observed in cerulenin-treated mutant strains. Further examination of mutant strains revealed differences in cell wall protein and polysaccharide compositions when compared with those of wild-type cells. These apparent alterations in cell surface components may be correlated with the reduced abilities of mutant strains to adhere, in vitro, to mammalian cells.


Assuntos
Antifúngicos/farmacologia , Candida albicans/genética , Cerulenina/farmacologia , Adesividade , Candida albicans/efeitos dos fármacos , Candida albicans/patogenicidade , Candida albicans/ultraestrutura , Membrana Celular/ultraestrutura , Parede Celular/ultraestrutura , Ceruletídeo , Resistência Microbiana a Medicamentos , Proteínas Fúngicas/metabolismo , Lipídeos/biossíntese , Mitocôndrias/ultraestrutura , Polissacarídeos/metabolismo
4.
J Infect Dis ; 152(4): 710-5, 1985 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-3900233

RESUMO

Two spontaneous cerulenin-resistant mutants of Candida albicans, 4918-2 and 4918-10, were unable to adhere in vitro in fibrin-platelet clots. Because in vitro adherence correlates well with colonization of nonbacterial thrombotic endocarditis on traumatized valvular endocardium, 50% infectious dose studies were performed with a rabbit model of endocarditis. Wild-type C. albicans required 10(3.6) +/- 0.12 cfu in comparison with 10(5.73) +/- 0.31 and 10(7.3) +/- 0.21 cfu for mutants 4918-2 and 4918-10, respectively. The relative avirulence of mutant strains in producing endocarditis was not attributed to accelerated clearance of these strains from the bloodstream. In fact, clearance of wild-type and mutant strains was almost identical. In the same animals renal candidiasis was observed with all strains of C. albicans, although the number of cfu per gram of kidney was higher after infection with wild-type C. albicans. Thus, strains of C. albicans with reduced ability to adhere in vitro to a fibrin-platelet matrix are relatively avirulent in the rabbit endocarditis model.


Assuntos
Candida albicans/patogenicidade , Endocardite/etiologia , Adesividade , Animais , Candida albicans/imunologia , Candidíase/etiologia , Cerulenina/farmacologia , Feminino , Imunização , Nefropatias/etiologia , Macrófagos/imunologia , Mutação , Fagocitose , Coelhos , Virulência
5.
Antimicrob Agents Chemother ; 24(3): 401-8, 1983 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-6357077

RESUMO

Candida albicans germination in liquid medium was inhibition by the antilipogenic agent cerulenin and the fatty acid sodium butyrate. Although these inhibitors prevented germ tube emergence at concentrations of 1 microgram/ml and 20 mM, respectively, neither significantly affected cell viability as judged by trypan blue staining or the rate of protein biosynthesis throughout the time course of the experiments. Cerulenin treatment resulted in inhibition of lipid biosynthesis, but lipid biosynthetic capabilities remained unaltered in sodium butyrate-supplemented cultures. Because each inhibitor blocks germination by different mechanisms, their utility in distinguishing events directly correlated to germination was examined. In this context, chitin synthase activity was inhibited by both compounds, confirming the importance of chitin biosynthesis in C. albicans germination.


Assuntos
Antifúngicos/farmacologia , Butiratos/farmacologia , Candida albicans/efeitos dos fármacos , Cerulenina/farmacologia , Ácido Butírico , Candida albicans/crescimento & desenvolvimento , Candida albicans/metabolismo , Quitina/biossíntese , Proteínas Fúngicas/biossíntese , Lipídeos/biossíntese , Ácido Palmítico , Ácidos Palmíticos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...